Ascent Wealth Partners’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-8,574
Closed -$2.11M 146
2022
Q3
$2.11M Sell
8,574
-628
-7% -$170K 0.5% 55
2022
Q2
$2.27M Buy
9,202
+28
+0.3% +$7.56K 0.51% 51
2022
Q1
$3.04M Buy
9,174
+74
+0.8% +$22.8K 0.57% 50
2021
Q4
$3.27M Buy
9,100
+303
+3% +$102K 0.58% 52
2021
Q3
$2.86M Buy
8,797
+59
+0.7% +$20K 0.55% 52
2021
Q2
$2.73M Sell
8,738
-250
-3% -$76.7K 0.52% 53
2021
Q1
$2.87M Sell
8,988
-67
-0.7% -$21.4K 0.62% 48
2020
Q4
$2.94M Sell
9,055
-88
-1% -$24.3K 0.65% 50
2020
Q3
$2.53M Buy
9,143
+368
+4% +$106K 0.65% 47
2020
Q2
$2.12M Buy
8,775
+1,374
+19% +$276K 0.62% 47
2020
Q1
$1.07M Buy
7,401
+508
+7% +$84.3K 0.39% 54
2019
Q4
$1.18M Sell
6,893
-251
-4% -$46.5K 0.33% 60
2019
Q3
$1.27M Buy
7,144
+1,752
+32% +$379K 0.39% 60
2019
Q2
$1.4M Buy
5,392
+606
+13% +$161K 0.43% 58
2019
Q1
$1.37M Buy
4,786
+516
+12% +$171K 0.45% 57
2018
Q4
$1.39M Buy
4,270
+9
+0.2% +$3.13K 0.54% 54
2018
Q3
$1.92M Buy
4,261
+15
+0.4% +$5.91K 0.61% 52
2018
Q2
$1.74M Sell
4,246
-256
-6% -$92.7K 0.61% 51
2018
Q1
$1.31M Sell
4,502
-63
-1% -$16K 0.48% 53
2017
Q4
$855K Sell
4,565
-31
-0.7% -$5.79K 0.32% 66
2017
Q3
$775K Buy
4,596
+148
+3% +$22.4K 0.31% 65
2017
Q2
$637K Buy
4,448
+14
+0.3% +$1.88K 0.27% 71
2017
Q1
$555K Sell
4,434
-26
-0.6% -$3.01K 0.25% 74
2016
Q4
$502K Buy
4,460
+1,035
+30% +$120K 0.25% 79
2016
Q3
$441K Sell
3,425
-5
-0.1% -$599 0.22% 81
2016
Q2
$375K Buy
+3,430
New +$341K 0.19% 85

Other funds holding ABMD

Ascent Wealth Partners's ABMD Position: Q4 2022 in Review

Ascent Wealth Partners sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 8,574 shares — an estimated $2.11M sold.

Ascent Wealth Partners first reported a position in ABMD in Q2 2016 and held it in 26 quarters. The position peaked at $3.27M in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Ascent Wealth Partners reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Ascent Wealth Partners sold 8,574 Abiomed Inc shares in Q4 2022, an estimated $2.11M.
  • Ascent Wealth Partners first reported a position in Abiomed Inc in Q2 2016 and held it in 26 quarters.
  • Ascent Wealth Partners's Abiomed Inc position peaked at $3.27M in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Ascent Wealth Partners's 13F filing for Q4 2022, filed 2 Feb 2023.